效应器
生物
免疫系统
跨膜蛋白
先天免疫系统
免疫
细菌
计算生物学
微生物学
细菌细胞结构
噬菌体
药物发现
小分子
致病菌
获得性免疫系统
噬菌体疗法
细胞
跨膜结构域
细胞毒性T细胞
细胞生物学
病毒学
信号转导
化学
细菌病毒
噬菌体展示
细菌蛋白
作者
Marian Aba Addo,V N Damodaran,Joseph P. Gerdt
标识
DOI:10.1021/acschembio.6c00068
摘要
The increasing prevalence of multidrug-resistant bacteria has intensified the search for alternative therapeutic strategies. Bacteriophages (the natural viral predators of bacteria) are one promising solution. However, bacterial immune systems confer phage resistance, which can limit the efficacy of phage therapies. Small-molecule modulators of bacterial immunity are a promising but underexplored strategy to enhance phage therapy. We report the first small-molecule inhibitors of the Pycsar immune system, a 3′,5′-cCMP signal-based defense mechanism, in bacteria. These inhibitors exhibit efficacy in Escherichia coli cells, enabling phage Bas34 to overcome Pycsar-mediated resistance. The Pycsar system relies on two proteins: a CTP cyclase, which generates the cCMP signal, and a cCMP-activated transmembrane effector, which disrupts the bacterial membrane of the host cells and prevents phage reproduction. Our findings reveal that the identified inhibitors specifically target the cytotoxic effects of the transmembrane effector rather than the signal-producing cyclase. These molecules highlight the promise of chemical modulators to suppress bacterial immunity and, thereby, expand the therapeutic potential of bacteriophages against multidrug-resistant pathogens.
科研通智能强力驱动
Strongly Powered by AbleSci AI